5-bromo-6-(((2-hydroxyethyl)amino)methyl)pyrimidine-2,4(1H,3H)-dione

ID: ALA4445259

PubChem CID: 155517383

Max Phase: Preclinical

Molecular Formula: C7H10BrN3O3

Molecular Weight: 264.08

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1[nH]c(CNCCO)c(Br)c(=O)[nH]1

Standard InChI:  InChI=1S/C7H10BrN3O3/c8-5-4(3-9-1-2-12)10-7(14)11-6(5)13/h9,12H,1-3H2,(H2,10,11,13,14)

Standard InChI Key:  WPOYLHRYOMEKLS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 14 14  0  0  0  0  0  0  0  0999 V2000
    4.2168  -13.4628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2168  -14.2879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9288  -14.6962    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6408  -14.2879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6408  -13.4628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9288  -13.0462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5028  -14.7014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9288  -12.2212    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3547  -14.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0698  -14.2899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3565  -13.0525    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    7.7837  -14.7034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4987  -14.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2127  -14.7055    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  7  2  0
  6  8  2  0
  4  9  1  0
  9 10  1  0
  5 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4445259

    ---

Associated Targets(Human)

TYMP Tclin Thymidine phosphorylase (504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 264.08Molecular Weight (Monoisotopic): 262.9906AlogP: -1.09#Rotatable Bonds: 4
Polar Surface Area: 97.98Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.82CX Basic pKa: 7.17CX LogP: -1.96CX LogD: -1.84
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.52Np Likeness Score: -0.29

References

1. de Moura Sperotto ND, Deves Roth C, Rodrigues-Junior VS, Ev Neves C, Reisdorfer Paula F, da Silva Dadda A, Bergo P, Freitas de Freitas T, Souza Macchi F, Moura S, Duarte de Souza AP, Campos MM, Valim Bizarro C, Santos DS, Basso LA, Machado P..  (2019)  Design of Novel Inhibitors of Human Thymidine Phosphorylase: Synthesis, Enzyme Inhibition, in Vitro Toxicity, and Impact on Human Glioblastoma Cancer.,  62  (3): [PMID:30615449] [10.1021/acs.jmedchem.8b01305]

Source